The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy
Roger A. Rodby, Chion-Fang Chiou, Jeff Borenstein, Allison Smitten, Nishan Sengupta, Andrew J. Palmer, Stéphane Roze, Lieven Annemans, Teresa A. Simon, Roland S. Chen, Edmund J. LewisVolume:
25
Year:
2003
Language:
english
DOI:
10.1016/s0149-2918(03)80208-4
File:
PDF, 1.16 MB
english, 2003